Ironwood Financial’s iShares Biotechnology ETF IBB Stock Holding History

Ironwood Financial’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-11	Closed	-$2K	–	300
2021 Q3	$2K	Hold	11	–	–	﹤0.01%	508
2021 Q2	$2K	Hold	11	–	–	﹤0.01%	501
2021 Q1	$2K	Buy	+11	New	+$1.75K	﹤0.01%	482
2015 Q1	–	Sell	-165	Closed	-$17K	–	379
2014 Q4	$17K	Buy	+165	New	+$16K	0.01%	147

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Ironwood Financial's IBB Position: Q4 2021 in Review

Ironwood Financial sold out of iShares Biotechnology ETF (IBB) in Q4 2021, closing a stake of 11 shares — an estimated $2K sold.

Ironwood Financial first reported a position in IBB in Q4 2014 and held it in 4 quarters. The position peaked at $17K in Q4 2014. 962 funds tracked by Wall St. Rank hold IBB as of Q4 2021.

Ironwood Financial reported no remaining iShares Biotechnology ETF position as of Q4 2021 after selling out during the quarter.
Ironwood Financial sold 11 iShares Biotechnology ETF shares in Q4 2021, an estimated $2K.
Ironwood Financial first reported a position in iShares Biotechnology ETF in Q4 2014 and held it in 4 quarters.
Ironwood Financial's iShares Biotechnology ETF position peaked at $17K in Q4 2014.
962 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2021.

Based on Ironwood Financial's 13F filing for Q4 2021, filed 28 Jan 2022.